Literature DB >> 16227353

NOD2 regulation of Toll-like receptor responses and the pathogenesis of Crohn's disease.

T Watanabe1, A Kitani, W Strober.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16227353      PMCID： PMC1774769          DOI： 10.1136/gut.2005.071795

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  43 in total

1.  A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

Authors:  S R Targan; S B Hanauer; S J van Deventer; L Mayer; D H Present; T Braakman; K L DeWoody; T F Schaible; P J Rutgeerts
Journal:  N Engl J Med       Date:  1997-10-09       Impact factor: 91.245

2.  The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.

Authors:  Derek W Abbott; Andrew Wilkins; John M Asara; Lewis C Cantley
Journal:  Curr Biol       Date:  2004-12-29       Impact factor: 10.834

3.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

4.  Muramyldipeptide and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture.

Authors:  A Uehara; S Yang; Y Fujimoto; K Fukase; S Kusumoto; K Shibata; S Sugawara; H Takada
Journal:  Cell Microbiol       Date:  2005-01       Impact factor: 3.715

5.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.

Authors:  C L Wilson; A J Ouellette; D P Satchell; T Ayabe; Y S López-Boado; J L Stratman; S J Hultgren; L M Matrisian; W C Parks
Journal:  Science       Date:  1999-10-01       Impact factor: 47.728

6.  Anti-interleukin-12 antibody for active Crohn's disease.

Authors:  Peter J Mannon; Ivan J Fuss; Lloyd Mayer; Charles O Elson; William J Sandborn; Daniel Present; Ben Dolin; Nancy Goodman; Catherine Groden; Ronald L Hornung; Martha Quezado; Zhiqiong Yang; Markus F Neurath; Jochen Salfeld; Geertruida M Veldman; Ullrich Schwertschlag; Warren Strober
Journal:  N Engl J Med       Date:  2004-11-11       Impact factor: 91.245

7.  Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.

Authors:  Fabio Martinon; Laetitia Agostini; Etienne Meylan; Jürg Tschopp
Journal:  Curr Biol       Date:  2004-11-09       Impact factor: 10.834

8.  Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing.

Authors:  Shin Maeda; Li-Chung Hsu; Hongjun Liu; Laurie A Bankston; Mitsutoshi Iimura; Martin F Kagnoff; Lars Eckmann; Michael Karin
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

9.  The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria.

Authors:  Tomonori Hirotani; Pui Y Lee; Hirotaka Kuwata; Masahiro Yamamoto; Makoto Matsumoto; Ichiro Kawase; Shizuo Akira; Kiyoshi Takeda
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

10.  Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome.

Authors:  Nobuo Kanazawa; Ikuo Okafuji; Naotomo Kambe; Ryuta Nishikomori; Mami Nakata-Hizume; Sonoko Nagai; Akihiko Fuji; Takenosuke Yuasa; Akira Manki; Yoshihiko Sakurai; Mitsuru Nakajima; Hiroko Kobayashi; Ikuma Fujiwara; Hiroyuki Tsutsumi; Atsushi Utani; Chikako Nishigori; Toshio Heike; Tatsutoshi Nakahata; Yoshiki Miyachi
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113
View more
  25 in total

Review 1.  The response of human dendritic cells to co-ligation of pattern-recognition receptors.

Authors:  Tanja Dzopalic; Ivan Rajkovic; Ana Dragicevic; Miodrag Colic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  NOD2 transgenic mice exhibit enhanced MDP-mediated down-regulation of TLR2 responses and resistance to colitis induction.

Authors:  Zhiqiong Yang; Ivan J Fuss; Tomohiro Watanabe; Naoki Asano; Michael P Davey; James T Rosenbaum; Warren Strober; Atsushi Kitani
Journal:  Gastroenterology       Date:  2007-07-25       Impact factor: 22.682

Review 3.  Do we really understand what the immunological disturbances in inflammatory bowel disease mean?

Authors:  Epameinondas V Tsianos; Konstantinos Katsanos
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

4.  NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway.

Authors:  Tomohiro Watanabe; Naoki Asano; Stefan Fichtner-Feigl; Peter L Gorelick; Yoshihisa Tsuji; Yuko Matsumoto; Tsutomu Chiba; Ivan J Fuss; Atsushi Kitani; Warren Strober
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

Review 5.  Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance.

Authors:  Matthew J Hamilton; Scott B Snapper; Richard S Blumberg
Journal:  J Gastroenterol       Date:  2012-01-05       Impact factor: 7.527

Review 6.  Role of genetics in the diagnosis and prognosis of Crohn's disease.

Authors:  Epameinondas V Tsianos; Konstantinos H Katsanos; Vasileios E Tsianos
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

7.  Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.

Authors:  Praveen Prakhar; Sahana Holla; Devram Sampat Ghorpade; Martine Gilleron; Germain Puzo; Vibha Udupa; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

8.  Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis.

Authors:  Tsung-Chieh Shih; Sen-Yung Hsieh; Yi-Yueh Hsieh; Tse-Chin Chen; Chien-Yu Yeh; Chun-Jung Lin; Deng-Yn Lin; Cheng-Tang Chiu
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  Impairment of mitochondrial acetoacetyl CoA thiolase activity in the colonic mucosa of patients with ulcerative colitis.

Authors:  Srikanth Santhanam; Aparna Venkatraman; Balakrishnan S Ramakrishna
Journal:  Gut       Date:  2007-05-04       Impact factor: 23.059

10.  Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels.

Authors:  Jinong Feng; Zhifang Zhang; Wenyan Li; Xiaoming Shen; Wenjia Song; Chunmei Yang; Frances Chang; Jeffrey Longmate; Claudia Marek; R Paul St Amand; Theodore G Krontiris; John E Shively; Steve S Sommer
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.